Mechanisms for muscle health in the critically ill patient

Critical Care Nursing Quarterly

Volumn 36, Issue 1, 2013, Pages 5-16

  Winkelman, Chris ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

ICU acquired weakness; muscle atrophy; muscle physiology; proteomics

Indexed keywords

CALPAIN; CASPASE 3; CONTRACTILE PROTEIN; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; MUSCLE PROTEIN; SOMATOMEDIN;

ACTIN FILAMENT; ARTIFICIAL VENTILATION; BIOENERGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; EDITORIAL; ELECTROSTIMULATION; EXERCISE; GLUCOSE TRANSPORT; HEART FAILURE; HUMAN; HYPOXIA; IMMOBILIZATION; INTENSIVE CARE UNIT ACQUIRED WEAKNESS; INTRACELLULAR SIGNALING; KETOACIDOSIS; KIDNEY DISEASE; KIDNEY INJURY; LACTIC ACIDOSIS; MALNUTRITION; MECHANICAL STRESS; MECHANOTRANSDUCTION; METABOLIC ACIDOSIS; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE MASS; MUSCLE STRETCHING; NEUROMUSCULAR ELECTRICAL STIMULATION; POSITIVE END EXPIRATORY PRESSURE; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEOMICS; RENAL REPLACEMENT THERAPY; SKELETAL MUSCLE; TENSILE STRENGTH; WEAKNESS;

CRITICAL ILLNESS; EARLY AMBULATION; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; SIGNAL TRANSDUCTION;

EID: 84871737181     PISSN: 08879303     EISSN: 15505111     Source Type: Journal    
DOI: 10.1097/CNQ.0b013e318275071d     Document Type: Editorial

References (64)

1. Hall JE. Guyton and Hall Textbook of Medical Physiology. 12th ed. Philadelphia, PA: Elsevier; 2011.
2. Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1772-1774.
3. Koeppen BM, Stanton BA. Berne & Levy Physiology. Philadelphia, PA: Elseveir; 2010.
4. Puthucheary Z, Montgomery H, Moxham J, Harridge S, Hart N. Structure to function: muscle failure in critically ill patients. J Physiol. 2010;588(pt 23):4641-4648.
5. Hermans G, Vanhorebeek I, Derde S, Van den Berghe G. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med. 2009;37(10 suppl):S391-S397.
6. Lacomis D. Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis. 2011;12(4):197-218.
7. De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30(6):1117-1121.
8. Sharshar T, Bastuji-Garin S, Stevens RD, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med. 2009;37(12):3047-3053.
9. Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37(10 suppl):S354-S367.
10. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931-941.
11. NCBI. Homo sapiens complex locus MTOR, encoding mechanistic target of rapamycin (serine/threonine kinase). http://www.ncbi.nlm.nih.gov/IEB/Research/ Acembly/av.cgi?db=human&c=Gene&l&MTOR. Accessed 2012.
12. Gruther W, Benesch T, Zorn C, et al. Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer. J Rehabil Med. 2008;40(3):185-189.
13. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005;11(2):126-132.
14. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Crit Care Med. 2010;38(10 suppl):S676-S682.
15. Bierbrauer J, Koch S, Olbricht C, et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med. 2012;40(2):647-650.
16. Derde S, Hermans G, Derese I, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med. 2012;40(1):79-89.
17. van Hees HW, Schellekens WJ, Linkels M, et al. Plasma from septic shock patients induces loss of muscle protein. Crit Care. 2011;15(5):R233.
18. English KL, Paddon-Jones D. Protecting muscle mass and function in older adults during bed rest. Curr Opin Clin Nutr Metab Care. 2010;13(1):34-39.
19. Manetos C, Dimopoulos S, Tzanis G, et al. Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure. J Heart Lung Transplant. 2011;30(12):1403-1408.
20. Saini A, Faulkner S, Al-Shanti N, Stewart C. Powerful signals for weak muscles. Ageing Res Rev. 2009;8(4):251-267.
21. West DW, Burd NA, Staples AW, Phillips SM. Human exercise-mediated skeletal muscle hypertrophy is an intrinsic process. Int J Biochem Cell Biol. 2010;42(9):1371-1375.
22. Reid MB, Moylan JS. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol. 2011;589(pt 9):2171-2179.
23. Reid MB, Li YP. Cytokines and oxidative signalling in skeletal muscle. Acta Physiol Scand. 2001;171(3):225-232.
24. Abate M, Schiavone C, Pelotti P, Salini V. Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy. Int J Immunopathol Pharmacol. 2010;23(4):997-1003.
25. Frost RA, Lang CH. Skeletal muscle cytokines: regulation by pathogen-associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care. 2005;8(3):255-263.
26. Rabuel C, Renaud E, Brealey D, et al. Human septic myopathy: induction of cyclooxygenase, heme oxygenase and activation of the ubiquitin proteolytic pathway. Anesthesiology. 2004;101(3):583-590.
27. Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 2011;25(5):811-816.
28. Pedersen BK. The diseasome of physical inactivity-and the role of myokines in muscle-fat cross talk. J Physiol. 2009;587(pt 23):5559-5568.
29. Banduseela VC, Ochala J, Chen YW, et al. Gene expression and muscle fiber function in a porcine ICU model. Physiol Genomics. 2009;39(3):141-159.
30. Angel MJ, Bril V, Shannon P, Herridge MS. Neuromuscular function in survivors of the acute respiratory distress syndrome. Can J Neurol Sci. 2007;34(4):427-432.
31. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.
32. Teener JW, Rich MM. Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil. 2006;27(5-7):291-296.
33. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46(3):731-736.
34. Ali NA, O'Brien JM Jr, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261-268.
35. Bahadur K, Jones G, Nitoumenopoulas G. An observational study of sitting out of bed in tracheostomised patients in the intensive care unit. Physiotherapy. 2008;94:300-305.
36. Morris PE, Griffin L, Berry M, et al. Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure. Am J Med Sci. 2011;341(5):373-377.
37. Needham DM, Korupolu R, Zanni JM, et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project. Arch Phys Med Rehabil. 2010;91(4):536-542.
38. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678):1874-1882.
39. Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009;37(9):2499-2505.
40. Routsi C, Gerovasili V, Vasileiadis I, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74.
41. Gerovasili V, Stefanidis K, Vitzilaios K, et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care. 2009;13(5):R161. doi:10.1186/cc8123. http://www. ncbi.nlm.nih.gov/pubmed/19814793. Accessed October16, 2012.
42. Kho ME, Truong AD, Brower RG, et al. Neuromuscular electrical stimulation for intensive care unitacquired weakness: protocol and methodological implications for a randomized, sham-controlled, phase II trial. Phys Ther. 2012. doi:10.2522/ptj.20110437. http://www.ncbi.nlm.nih.gov/pubmed/22421734. Accessed October16, 2012.
43. Gruther W, Kainberger F, Fialka-Moser V, et al. Effects of neuromuscular electrical stimulation on muscle layer thickness of knee extensor muscles in intensive care unit patients: a pilot study. J Rehabil Med. 2010;42(6):593-597.
44. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360(9328):219-223.
45. Jones SW, Hill RJ, Krasney PA, O'Conner B, Peirce N, Greenhaff PL. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J. 2004;18(9):1025-1027.
46. Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletalmuscle atrophy. JMol Med (Berl). 2008;86(10):1113-1126.
47. Spate U, Schulze PC. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004;7(3):265-269.
48. Sorimachi H, Ono Y. Regulation and physiological roles of the calpain system in muscular disorders [published online ahead of print April 27, 2012]. Cardiovasc Res. 2012;96(1):11-22.
49. Ono Y, Sorimachi H. Calpains: an elaborate proteolytic system. Biochim Biophys Acta. 2012;1824(1): 224-236.
50. Smuder AJ, HudsonMB, Nelson WB, Kavazis AN, Powers SK. Nuclear factor-kappaB signaling contributes to mechanical ventilation-induced diaphragm weakness*. Crit Care Med. 2012;40(3):927-934.
51. Baar K, Nader G, Bodine S. Resistance exercise, muscle loading/unloading and the control ofmusclemass. Essays Biochem. 2006;42:61-74.
52. Kandarian SC, Jackman RW. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve. 2006;33(2):155-165.
53. Argiles JM, Lopez-Soriano FJ, Busquets S. Mechanisms to explain wasting of muscle and fat in cancer cachexia. Curr Opin Support Palliat Care. 2007;1(4):293-298.
54. Nelson WB, Smuder AJ, Hudson MB, Talbert EE, Powers SK. Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit Care Med. 2012;40(6):1857-1863.
55. Goodman CA, Mayhew DL, Hornberger TA. Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass. Cell Signal. 2011;23(12):1896-1906.
56. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med. 2003;9(8):344-350.
57. Hornberger TA. Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol. 2011;43(9):1267-1276.
58. Pasiakos SM. Exercise and amino acid anabolic cell signaling and the regulation of skeletal muscle mass. Nutrients. 2012;4(7):740-758.
59. Goodman CA, Frey JW, Mabrey DM, et al. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol. 2011;589(pt 22):5485-5501.
60. Kumar V, Atherton PJ, Selby A, et al. Muscle protein synthetic responses to exercise: effects of age, volume, and intensity. J Gerontol A Biol Sci Med Sci. 2012.
61. Drummond MJ, Dreyer HC, Fry CS, Glynn EL, Rasmussen BB. Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J Appl Physiol. 2009;106(4):1374-1384.
62. Smuder AJ, Min K, Hudson MB, et al. Endurance exercise attenuates ventilator-induced diaphragm dysfunction. J Appl Physiol. 2012;112(3):501-510.
63. McGinley C, Shafat A, Donnelly AE. Does antioxidant vitamin supplementation protect against muscle damage? Sports Med. 2009;39(12):1011- 1032.
64. Wernerman J. Micronutrients against oxidative stress-time for clinical recommendations? Crit Care. 2012;16(3):124.